|
 |
Name:
Designation:
Areas of Specialization:
E-mail: |
Pankaj Suman
Scientist-C
Aptamer based diagnostics for animal diseases; Immunological memory and Immunity; Applied animal nutrition
pankajsuman[at]niab[dot]org[dot]in |
|
|
|
Education and training:
Dr. Pankaj Suman completed B.V.Sc. (2004) from Maharashtra Animal and Fishery Sciences University, Nagpur, M.Sc. (2006; Biotechnology) from Indian Institute of Technology Roorkee and Ph.D. (2011; Immunology) from the National Institute of Immunology (NII), New Delhi. He also worked as visiting scholar at the Friedrich-Schiller University, Jena, Germany (2007-2010). Later, he worked as a Post-doctoral Fellow (2011-2013) at NII, New Delhi, and then as Assistant Professor (2013-2014) at Amity University, Noida, Uttar Pradesh. Before joining the NIAB in 2017, he was associated with the Animal Husbandry and Fishery Resources Department, Govt. of Bihar as a Veterinary Clinician.
Research experience and interests:
Dr. Suman’s experience spans reproductive biology, immunology and veterinary clinical medicine. In the past, he has made significant contribution in understanding the molecular mechanisms behind the immunological basis of pregnancy. His laboratory at NIAB is dedicated to address the clinical problems in veterinary medicine through developing affordable diagnostics, designer probiotics and improving innate & adaptive immunity.
Selected awards, honours and fellowships:
-
Prof. G. P. Talwar Young Scientist Award for outstanding contribution in research in reproductive health (2014)
-
Travel Grants: United States Department of Agriculture (USDA) (2010); Department of Science and Technology (DST), Govt. of India (2010)
-
Best discussant Award, EMBIC summer School, Jena, Germany (2007)
-
CSIR-Junior Research Fellowship-NET (2006)
-
Dr. B. L. Purohit medal in Veterinary Pathology, MAFSU (2004)
Selected publications:
-
Godbole G*, Suman P*, Malik A*, Galvankar M, Joshi N, Fazleabas A, Gupta SK, Modi D. 2017. Decrease in Expression of HOXA10 in the Decidua after Embryo Implantation Promotes Trophoblast Invasion. Endocrinology doi: 10.1210/en.2017-00032. *Equal contribution
-
Suman P*, Gandhi S, Kumar P, Garg K. 2017. Prospects of electrochemical immunosensors for early diagnosis of preeclampsia. American Journal of Reproductive Immunology 77 (1):e12584. *Corresponding Author
-
Malhotra SS, Suman P, Gupta SK. 2015. Alpha or beta human chorionic gonadotropin knockdown decrease BeWo cell fusion by down-regulating PKA and CREB activation. Scientific Reports 5:11210.
-
Suman P, Gupta SK. 2014. STAT3 and ERK1/2 cross-talk in leukaemia inhibitory factor mediated trophoblastic JEG-3 cell invasion and expression of mucin 1 and Fos. American Journal of Reproductive Immunology 72(1):65-74.
-
Suman P, Shembekar N, Gupta SK. 2013. LIF increases the invasiveness of trophoblastic cells through integrated
increase in the expression of adhesion molecules and pappalysin 1 with a concomitant decrease in the expression of TIMPs. Fertility and Sterility 99(2):533-42.
-
Suman P, Gupta SK. 2012. Comparative analysis of the invasion-associated genes expression pattern in first trimester trophoblastic (HTR-8/SVneo) and JEG-3 choriocarcinoma cells. Placenta 33(10):874-877.
-
Suman P, Godbole G, Thakur R, Morales-Prieto DM, Modi DN, Markert UR, Gupta SK. 2012. AP-1 transcription factors, mucin-type molecules and MMPs regulate the IL-11 mediated invasiveness of JEG-3 and HTR-8/SVneo trophoblastic cells. PLoS One 7: e29745.
-
Godbole G, Suman P, Gupta SK, Modi D (2011) Decidualized endometrial stromal cell derived factors promote trophoblast invasion. Fertility and Sterility 95(4):1278-1283.
-
Suman P, Poehlmann TG, Prakash GJ, Markert UR, Gupta SK (2009) Interleukin-11 increases invasiveness of JEG-3 choriocarcinoma cells by modulating STAT3 expression. Journal of Reproductive Immunology
82(1):1-11.
-
Choudhury S, Kakkar V, Suman P, Chakrabarti K, Vrati S, Gupta SK. 2009. Immunogenicity of zona pellucida glycoprotein-3 and spermatozoa YLP(12) peptides presented on Johnson grass mosaic virus-like particles. Vaccine 27(22):2948-2953.
Detailed profile
|
|
|
|